Over the past year, owing to the emergent demand for the search for potential COVID-19
therapeutics, identifying alternative candidates from biological sources is one of the …

Simple Summary The ongoing coronavirus disease-2019 (COVID-19) pandemic shows
unprecedented challenges for the worldwide healthcare system. Despite the large clinical …

SARS-CoV-2 is the causative agent of the COVID-19 pandemic. This in silico study aimed to
elucidate therapeutic efficacies against SARS-CoV-2 of phyco-compounds from the …

With the rapid spread of multi-drug-resistant bacteria and more infectious or aggressive
variants of SARS-CoV-2, it is critical to develop drugs that can quickly adapt to evolving …

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has led to more than 5 million deaths worldwide to …

The COVID-19 pandemic has severely destructed human life worldwide, with no suitable
treatment until now. SARS-CoV-2 virus is unprecedented, resistance against number of …

A global health concern has emerged as a response to the recent SARS-CoV-2 pandemic.
The identification and inhibition of drug targets of SARS-CoV-2 is a decisive obligation of …

Marine species are known as rich sources of metabolites largely involved in the
pharmaceutical industry. This study aimed to evaluate in silico the effect of natural …

Biomolecules of marine origin have many applications in the field of biotechnology and
medicine, but still hold great potential as bioactive substances against different diseases …

The novel β-coronavirus, SARS-CoV-2, responsible for the coronavirus disease 2019
(COVID-19) emerged in China in December 2019. Due to its high transmission and infection …